The comparison of FAM13C with established molecular features in prostate cancer demonstrated that increased FAM13C expression is strongly associated with the subset of tumors harboring the TMPRSS2:ERG gene fusion. This evidence concerns the gene TMPRSS2 and Familial prostate cancer.